ODDITY to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
Rhea-AI Summary
ODDITY (NASDAQ: ODD) will release its fourth quarter and full year 2025 financial results before market open on February 25, 2026, followed by a conference call at 8:30 a.m. ET.
According to the company, a live webcast and dial-in access are available, with a replay archived on the investor website for seven days. Replay access code: 13758683.
Positive
- None.
Negative
- None.
News Market Reaction – ODD
On the day this news was published, ODD gained 6.77%, reflecting a notable positive market reaction. Argus tracked a peak move of +6.9% during that session. Our momentum scanner triggered 15 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $115M to the company's valuation, bringing the market cap to $1.82B at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers show mixed moves: EEFT +3.08%, RELY +1.95%, PGY +0.24%, while CALX -1.3% and TENB -3.79%. With ODD flat on an earnings-date notice, action appears stock-specific rather than a broad sector trend.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 19 | Q3 2025 results | Positive | +1.6% | Record Q3 results and raised full-year 2025 financial outlook. |
| Nov 18 | Platform launch | Positive | -1.7% | Launch of METHODIQ AI-driven telehealth dermatology platform. |
| Oct 22 | Earnings date notice | Neutral | -3.9% | Scheduling announcement for Q3 2025 earnings release and call logistics. |
Operationally strong news (record results, product launches) has produced mixed near-term price reactions, while prior earnings-date scheduling alone coincided with a negative move.
Recent news shows ODDITY delivering strong execution. On Nov 19, 2025, it reported record Q3 results with raised full-year 2025 outlook and the stock rose 1.59%. A day earlier, the formal launch of the METHODIQ telehealth platform saw a -1.67% reaction despite strategic significance. A prior earnings-date announcement on Oct 22, 2025 preceded a -3.86% move. Today’s scheduling of Q4 and full-year 2025 results fits this pattern of frequent investor updates.
Market Pulse Summary
The stock moved +6.8% in the session following this news. A strong positive reaction aligns with the company’s history of highlighting growth, such as record Q3 results and a raised 2025 outlook. However, prior product launches and even an earlier earnings-date notice saw mixed price responses, including moves of -1.67% and -3.86%. Investors weighing any sharp upside would need to consider how quickly enthusiasm could fade if upcoming financials on Feb 25, 2026 fail to meet expectations.
AI-generated analysis. Not financial advice.
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) (NASDAQ: ODD), today announced that it will release its fourth quarter and full year 2025 financial results before the market open on Wednesday, February 25, 2026, to be followed by a conference call at 8:30 a.m. Eastern Time.
Conference Call Details:
To participate in the conference call, please dial 1-877-407-9208 (US) or 1-201-493-6784 (international). To access the call, please reference the company name and call title: ODDITY Fourth Quarter and Full Year 2025 Earnings Call. A webcast of the call will be accessible on the Investors section of ODDITY’s website at https://investors.oddity.com. A recording will be available shortly after the conclusion of the call. To access the replay, please dial 1-844-512-2921 (US) or 1-412-317-6671 (international). The access code for the replay is 13758683. An archive of the webcast will be available on the Investors section of ODDITY’s website for seven days following the call.
About ODDITY
ODDITY is a consumer tech company that builds and scales digital-first brands to disrupt the offline-dominated beauty and wellness industries. The company serves approximately 60 million users with its AI-driven online platform, deploying data science to identify consumer needs, and developing solutions in the form of beauty and wellness products. ODDITY owns IL MAKIAGE, SpoiledChild and METHODIQ. The company operates with business headquarters in New York City, an R&D center in Tel Aviv, Israel, and a biotechnology lab in Boston.
Contacts
Press:
press@oddity.com
Investor:
investors@oddity.com